Skip to main content

Nyamyc

Generic: Nystatin

Verified·Apr 23, 2026
Manufacturer
Upsher-Smith Laboratories, LLC
NDC
0832-0465
RxCUI
584414
Route
TOPICAL
ICD-10 indication
B37.2

Affordability Check

How much will you actually pay for Nyamyc?

In 30 seconds, see every legitimate way to afford Nyamyc — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Nyamyc

What is this medication? Nyamyc is a prescription antifungal medication that contains the active ingredient nystatin. It is primarily used to treat various types of skin infections caused by fungi or yeast, specifically those belonging to the Candida family. This medication works by stopping the growth of the fungus, effectively clearing up the infection and relieving associated symptoms such as itching, redness, and discomfort. The medication is typically provided in the form of a topical powder, making it particularly useful for treating infections in moist areas of the body where skin rubs together. Common areas of application include skin folds, under the breasts, in the groin area, or between the toes. It is important to use the medication for the full length of time prescribed by a healthcare professional to ensure the infection is completely eradicated and does not return.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Nyamyc. Official source: DailyMed (NLM) · Label effective Jul 9, 2025

Indications and usage
INDICATIONS AND USAGE Nyamyc® (Nystatin Topical Powder, USP) is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. Nyamyc® (Nystatin Topical Powder, USP) is not indicated for systemic, oral, intravaginal or ophthalmic use.
Dosage and administration
DOSAGE AND ADMINISTRATION Very moist lesions are best treated with the topical dusting powder. Adults and Pediatric Patients (Neonates and Older) Apply to candidal lesions two or three times daily until healing is complete. For fungal infection of the feet caused by Candida species, the powder should be dusted on the feet, as well as, in all foot wear.
Contraindications
CONTRAINDICATIONS Nyamyc® (Nystatin Topical Powder, USP) is contraindicated in patients with a history of hypersensitivity to any of its components.
Adverse reactions
ADVERSE REACTIONS The frequency of adverse events reported in patients using nystatin topical preparations is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. [see PRECAUTIONS: General ].
Use in pregnancy
Pregnancy Teratogenic Effects Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether theses preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nyamyc® (Nystatin Topical Powder, USP) should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Nyamyc appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

52%

2,861 of 5,509 plans

Most common tier

Tier 2

On 34% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)92
29%
Tier 2 (generic)110
34%
Tier 3 (preferred brand)83
26%
Tier 4 (non-preferred brand)36
11%

Step therapy: 0% of formularies

Quantity limits: 70% of formularies

Coverage breadth: 321 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.